Imatinib interim therapy between chemotherapeutic cycles and in vivo purging prior to autologous stem cell transplantation, followed by maintenance therapy is a feasible treatment strategy in Philadelphia chromosome-positive acute lymphoblastic leuk (Q46661642)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Imatinib interim therapy between chemotherapeutic cycles and in vivo purging prior to autologous stem cell transplantation, followed by maintenance therapy is a feasible treatment strategy in Philadelphia chromosome-positive acute lymphoblastic leuk |
scientific article |
Statements
1 reference
Imatinib interim therapy between chemotherapeutic cycles and in vivo purging prior to autologous stem cell transplantation, followed by maintenance therapy is a feasible treatment strategy in Philadelphia chromosome-positive acute lymphoblastic leuk (English)
1 reference
Shin HJ
1 reference
Chung JS
1 reference
Cho GJ
1 reference
1 November 2005
1 reference
1 reference
36
1 reference
10
1 reference
917-918
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference